Document is current

Any future updates will be listed below

Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer

Crossref DOI link: https://doi.org/10.1186/s12967-016-0861-5

Published Online: 2016-05-03

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark